InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för inflammatorisk tarmsjukdom som kan hjälpa patienter tillbaka till ett normalt liv.
Stockholm, Sweden
Joined June 2016
- Tweets249
- Following6
- Followers247
- Likes1
Välkommen till InDex Pharmaceuticals Business Update-presentation i Stockholm den 9 maj, kl 13:00 till 15.30 CET news.cision.com/se/index-pha…
293
Welcome to an InDex Pharmaceuticals business update presentation in Stockholm on May 9, from 13:00 to 15.30 CET news.cision.com/index-pharma…
1
263
InDex Pharmaceuticals Holding AB (publ) kallar till årsstämma news.cision.com/se/index-pha…
235
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) news.cision.com/index-pharma…
183
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2022 news.cision.com/index-pharma…
158
InDex Pharmaceuticals Holding AB (publ) offentliggör årsredovisning för 2022 news.cision.com/se/index-pha…
136
InDex Pharmaceuticals meddelar positiva resultat från en farmakokinetikstudie (PK-studie) med cobitolimod news.cision.com/se/index-pha…
2
123
InDex Pharmaceuticals announces positive results from a pharmacokinetic (PK) study with cobitolimod news.cision.com/index-pharma…
1
91
InDex Pharmaceuticals deltar i ECCO-kongressen 2023 news.cision.com/se/index-pha…
1
101
InDex Pharmaceuticals to attend the ECCO 2023 congress news.cision.com/index-pharma…
99
InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2022 news.cision.com/se/index-pha…
84
InDex Pharmaceuticals Holding AB (publ) year-end report 2022 news.cision.com/index-pharma…
70
InDex Pharmaceuticals tillhandahåller kompletterande information om fas III-programmet CONCLUDE med cobitolimod news.cision.com/se/index-pha…
1
96
InDex Pharmaceuticals provides complementary information on the phase III program CONCLUDE with cobitolimod news.cision.com/index-pharma…
65
InDex Pharmaceuticals uppdaterar tidplanen för fas III-studien CONCLUDE med cobitolimod news.cision.com/se/index-pha…
133
InDex Pharmaceuticals updates the timeline of the phase III study CONCLUDE with cobitolimod news.cision.com/index-pharma…
72
InDex Pharmaceuticals Holding AB (publ) interim report January – September 2022 news.cision.com/index-pharma…
InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2022 news.cision.com/se/index-pha…
InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning inför årsstämman 2023 news.cision.com/se/index-pha…
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting news.cision.com/index-pharma…